Results 21 to 30 of about 104,921 (341)

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]

, 2011
Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Alexander Buchner, Alexander Roosen, Andersson KE, Chancellor MB, Christian G. Stief, Christian Gratzke, Cohen BL, Coyne KS, Eleopra R, Florian May, Garner CG, Jeffery S, Kalsi V, Lange DJ, Margit E. Mayer, Mehnert U, Mohanty NK, Ricarda M. Bauer, Shaban AM, Smith CP, Yasmin Hocaoglu   +20 more
core   +1 more source

Botulinum toxin for the treatment of lower limb cramp pain in patients with Amyotrophic Lateral Sclerosis [PDF]

, 2020
Background: Muscle cramps and pain associated with them can be seen in patients with amyotrophic lateral sclerosis (ALS) and are known to reduce the quality of life. Pharmacological treatment may not benefit all patients in treating these cramps.
Govindarajan, Raghav, Mehta, Tejas, Sommers, Richard   +2 more
core   +2 more sources

Molecular Aspects of Secretory Granule Exocytosis by Neurons and Endocrine Cells [PDF]

, 1994
Neuronal communication and endocrine signaling are fundamental for integrating the function of tissues and cells in the body. Hormones released by endocrine cells are transported to the target cells through the circulation.
Ahnert-Hilger G., Ahnert-Hilger G., Bader M. F., Baumert M., Bittner M. A., Bittner M. A., Bittner M. A., Blasi J., Elferink L. A., Fischer G., Geppert M., Halpern J. L., Hess S. D., Jahn R., MANFRED GRATZL, Marqueze-Pouey B., McMahon H. T., Schiavo G., Schiavo G., Schiavo G., Schmidle T., Shirataki H., Shoji-Kasai Y., Stecher B., Thomas L., Trimble W. S., Walch-Solimena C., Wright J. F., Yoshida A.   +28 more
core   +1 more source

Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction

Toxins, 2022
Dysphagia associated with upper esophageal sphincter (UES) dysfunction remarkably affects the quality of life of patients. UES injection of botulinum toxin is an effective treatment for dysphagia. In comparison with skeletal muscles of the limb and trunk,
Pengxu Wei
doaj   +1 more source

Uses of botulinum toxin in the management of patients with movement disorders: a national survey from India

Annals of Movement Disorders, 2020
Objective: The aim was to assess the opinion of the movement disorder society of India members regarding the uses of botulinum toxin in clinical practice.
Ashwin K Panda, Sanjay Pandey
doaj   +1 more source

Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia [PDF]

, 2016
Botulinum toxin type A (BoNT-A) injections are recommended for the management of upper limb spasticity (ULS) and cervical dystonia (CD). The main aim of this cost minimization analysis (CMA) was to compare the annual cost per patient for three BoNT-As ...
Bartolomei, Luigi, Bentivoglio, Anna Rita, Bizzarini, Massimo, Caglioni, Patrizia Maria, Cerbarano, Luana, Frontoni, Marco, Lus, Giacomo, Majorana, Giovanni, Nassetti, Stefania Alessandra, Osio, Maurizio, Ravasio, Roberto, Ravenni, Roberta, Santoro, Antonio, Smania, Nicola, Torlizzi, Flavia, Valvo, Sebastiana Claudia   +15 more
core   +1 more source

New technology to improve the thermal stability of botulinum toxin type D by biomimetic mineralization

Scientific Reports, 2021
The advanced biomimetic mineralization technology was applied to protect the Botulinum neurotoxin type D, and the processing of the mineralization granule of botulinum toxin type D was successfully screened.
Shengqing Li, Xiyun Zhang, Guoyuan Hu, Shuping Li, Zhining Li, Yuxia Fan, Yanming Zhang   +6 more
doaj   +1 more source

The binding of botulinum neurotoxins to different peripheral neurons [PDF]

, 2017
Botulinum neurotoxins are the most potent toxins known. The double receptor binding modality represents one of the most significant properties of botulinum neurotoxins and largely accounts for their incredible potency and lethality.
Rossetto, O.
core   +1 more source

Diffusion of Botulinum Toxins

Tremor and Other Hyperkinetic Movements, 2012
Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed. Many factors have been suggested to play a role but which have the most clinical relevance is a subject of much discussion.
Brodsky, Matthew A., Swope, David M., Grimes, David   +2 more
openaire   +5 more sources

Botulinum toxin type A in treatment of chronic migraine, spasticity and bruxism

Journal of Education, Health and Sport, 2023
Introduction: Nowadays, botulinum toxin has found use in many disease entities such as chronic migraine, spasticity, bruxism and many others. Among serotypes A-E, type A is mainly used in treatment.
Klaudia Kuliga, Katarzyna Dobko, Gabriela Frącz, Agata Glac, Kinga Musz, Natalia Sejnowska, Agnieszka Socha, Agata Surowiec, Kinga Śnieżek, Anna Zając   +9 more
doaj   +1 more source